Agenus (AGEN) Net Equity Issued and Repurchased (2010 - 2026)

Agenus' (AGEN) quarterly Net Equity Issued and Repurchased came in at $996000.0 in Q1 2026, down 84.3% year-on-year from $6.3 million in Q1 2025, and down 88.43% quarter-over-quarter from $8.6 million in Q4 2025.

Agenus (AGEN) Net Equity Issued and Repurchased (2010 - 2026) Analysis & Trends

Agenus' Net Equity Issued and Repurchased history runs 16 years deep, the most recent figure standing at $996000.0 for Q1 2026.

  • On a quarterly basis, Net Equity Issued and Repurchased fell 84.3% year-over-year to $996000.0 in Q1 2026; TTM through Mar 2026 was $30.8 million, a 38.72% increase from a year earlier, with the FY2025 full-year figure at $36.1 million, up 9.43% from the prior year.
  • Net Equity Issued and Repurchased fell to $996000.0 in Q1 2026 per AGEN's latest filing, from $8.6 million in the prior quarter.
  • Across five years, Net Equity Issued and Repurchased topped out at $60.6 million in Q1 2023 and bottomed at $996000.0 in Q1 2026.
  • The 5-year median for Net Equity Issued and Repurchased is $12.2 million (2025), against an average of $17.8 million.
  • Across the five-year window, Net Equity Issued and Repurchased slumped 95.29% in 2024 and surged 513.92% in 2025, its largest moves.
  • Year by year, Net Equity Issued and Repurchased stood at $24.0 million in 2022, then slumped by 58.36% to $10.0 million in 2023, then fell by 28.98% to $7.1 million in 2024, then gained by 21.52% to $8.6 million in 2025, then plunged by 88.43% to $996000.0 in 2026.
  • Per Business Quant, the three latest AGEN Net Equity Issued and Repurchased figures stand at $996000.0 (Q1 2026), $8.6 million (Q4 2025), and $9.0 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 163.10 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 141.90 Mn
10 Agenus 184.05 Mn 177.29 Mn 33.74 Mn 996,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 996,000.00
Mar 31, 2026 996,000.00
Dec 31, 2025 8.61 Mn
Dec 31, 2025 8.61 Mn
Sep 30, 2025 8.97 Mn
Sep 30, 2025 8.97 Mn
Jun 30, 2025 12.22 Mn
Jun 30, 2025 12.22 Mn
Mar 31, 2025 6.34 Mn
Mar 31, 2025 6.34 Mn
Dec 31, 2024 7.09 Mn
Dec 31, 2024 7.09 Mn
Sep 30, 2024 6.78 Mn
Sep 30, 2024 6.78 Mn
Jun 30, 2024 1.99 Mn
Jun 30, 2024 1.99 Mn
Mar 31, 2024 17.17 Mn
Mar 31, 2024 17.17 Mn
Dec 31, 2023 9.98 Mn
Dec 31, 2023 9.98 Mn